NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dow Inc. (“Dow” or the “Company”) (NYSE: DOW).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.    The investigation concerns whether Dow and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On July 24, 2025, Dow issued a ...

LOS ANGELES, July 28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fiserv, Inc. ("Fiserv" or "the Company") (NYSE: FI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between July 24, 2024 and July 22, 2025, inclusive (the "Class Period"), are encouraged ...

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Replimune Group, Inc. (NASDAQ: REPL) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Replimune, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/replimune-group-class-action-lawsuit. Investors have until September 22, 2025, to ask the Court to b ...

核心观点 - Pomerantz LLP正在调查Nutex Health Inc可能存在的证券欺诈或其他非法商业行为 [1] - 调查涉及Nutex及其部分高管和/或董事 [1] 事件背景 - Blue Orca Capital于2025年7月22日发布针对Nutex的做空报告 [2] - 报告指控Nutex因与第三方供应商HaloMD的关系面临诉讼风险 [2] - HaloMD近期被指控参与"协调欺诈计划"从保险公司骗取数百万美元 [2] 市场反应 - Blue Orca报告发布后 Nutex股价单日下跌11 18美元 跌幅达10 05% [3] - 股价从111 19美元跌至100 01美元 [3] 调查机构 - Pomerantz LLP在纽约 芝加哥 洛杉矶 伦敦和巴黎设有办事处 [4] - 该律所在公司 证券和反垄断集体诉讼领域享有盛誉 [4] - 由集体诉讼领域先驱Abraham L Pomerantz创立 [4] - 80多年来专注于证券欺诈 信托义务违约和公司不当行为的受害者权益 [4] - 曾为集体诉讼成员追回多笔数百万美元的赔偿 [4]

NEW YORK, July 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Encompass and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On July 15, ...

公司调查事件 - Telix Pharmaceuticals Limited因涉嫌证券欺诈或其他非法商业行为正接受Pomerantz LLP调查 [1] - 调查涉及公司及其部分高管和/或董事 [1] 股价影响 - Telix于2025年7月22日披露收到美国证券交易委员会 subpoena 要求提供前列腺癌治疗候选药物相关文件 [2] - 消息公布后 公司ADR价格下跌1 70美元 跌幅10 44% 至14 58美元/ADR [2] 调查背景 - Pomerantz LLP在证券集体诉讼领域具有80年历史 专注于证券欺诈 信托义务违约等案件 [3] - 该律所曾代表集体诉讼成员获得多笔数百万美元赔偿 [3]

NEW YORK, July 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fiserv, Inc. ("Fiserv" or the "Company") (NYSE: FI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Fiserv and certain of its officers and/or direc ...

NEW YORK, July 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dow Inc. ("Dow" or the "Company") (NYSE: DOW). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Dow and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On July 24, 2025, Dow issued a press release ...

NEW YORK, July 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Simulations Plus, Inc. ("Simulations Plus" or the "Company") (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Simulations Plus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] O ...

诉讼案件概述 - 罗森律师事务所代表在2024年7月24日至2025年7月23日期间购买Fiserv公司普通股的投资者提起集体诉讼 [1] - 诉讼指控Fiserv公司在上述期间做出虚假和误导性陈述或未披露关键信息 [5] 诉讼核心指控 - Fiserv因成本问题强制Payeezy平台商户迁移至Clover平台 导致Clover平台的收入增长和总支付量(GPV)暂时性不可持续增长 [5] - 大量Payeezy商户因Clover平台定价过高 系统兼容性问题和频繁宕机转向竞争对手解决方案 [5] - 商户流失导致Clover平台GPV增长显著放缓 收入增长不可持续 [5] - Fiserv在诉讼期间关于Clover增长策略 竞争力和业务前景的正面陈述存在重大虚假和误导性 [5] 律师事务所背景 - 罗森律师事务所在证券集体诉讼领域具有丰富经验 2017年证券集体诉讼和解数量排名第一 [4] - 该律所2019年为投资者追回超过4.38亿美元赔偿 [4] - 曾创下针对中国公司的最大规模证券集体诉讼和解记录 [4]